Gout and Hyperparathyroidism secondary

Summary:

Hyperparathyroidism secondary is found among people with Gout, especially for people who are male, 60+ old.

The study analyzes which people have Hyperparathyroidism secondary with Gout. It is created by eHealthMe based on reports of 190 people who have Gout from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Gout?

Gout (uric acid crystals building up in the body) is found to be associated with 1,148 drugs and 1,310 conditions by eHealthMe. Check the latest studies of Gout.

What is Hyperparathyroidism secondary?

Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary) is found to be associated with 697 drugs and 461 conditions by eHealthMe. Check the latest studies of Hyperparathyroidism secondary.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 23, 2026

190 people who have Gout and Hyperparathyroidism Secondary are studied.

Would you have Hyperparathyroidism secondary when you have Gout?

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Hyperparathyroidism secondary?

- Check whether Hyperparathyroidism secondary is associated with a drug or a condition

Related studies:

Treatments, associated drugs and conditions:

Gout (54,478 reports)
Hyperparathyroidism secondary (29,891 reports)

All the drugs that are associated with Hyperparathyroidism secondary:

Hyperparathyroidism secondary (697 drugs)

All the conditions that are associated with Hyperparathyroidism secondary:

Hyperparathyroidism secondary (461 conditions)

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Hyperparathyroidism secondary and Gout, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.